<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1607446</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2025.1607446</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A bioinformatics analysis of the correlation between hepatic ischemia&#x2013;reperfusion injury and postoperative cognitive dysfunction</article-title>
<alt-title alt-title-type="left-running-head">Hu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2025.1607446">10.3389/fgene.2025.1607446</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Qing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3020770/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Haijie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bao</surname>
<given-names>Yunfei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Zhihao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Hongbo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Jianling</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2111685/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Affiliated Hospital of Chengde Medical University</institution>, <institution>Hebei Province Key Laboratory of Pan-Vascular Diseases Chengde</institution>, <addr-line>Hebei</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Chengde Medical University</institution>, <addr-line>Chengde</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/574790/overview">Hari Prasad Osuru</ext-link>, University of Virginia, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2429997/overview">Munichandra Babu Tirumalasetty</ext-link>, New York University, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1973176/overview">Chiranjeevi Tikka</ext-link>, Indiana University School of Medicine, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Hongbo Zhang, <email>330541765@qq.com</email>; Jianling Li, <email>lyjianling@163.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1607446</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Hu, Liu, Bao, Feng, Zhang and Li.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Hu, Liu, Bao, Feng, Zhang and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Postoperative cognitive dysfunction (POCD) is a common postoperative complication that is prevalent in elderly people. An increasing number of elderly patients are undergoing surgery. As a result, the number of patients presenting with POCD is increasing. Previous studies have demonstrated that hepatic ischemia&#x2013;reperfusion injury (HIRI) in mice is associated with postoperative cognitive impairment. Therefore, this study investigated the relationship between POCD and HIRI using bioinformatics research methods.</p>
</sec>
<sec>
<title>Methods</title>
<p>The Gene Expression Omnibus (GEO) database GSE202565 and GeneCards data were selected for correlation analysis using bioinformatics analysis methods. The GSE112713 dataset from the GEO database was chosen for preliminary validation of the screened hub genes.</p>
</sec>
<sec>
<title>Results</title>
<p>We analyzed the dataset GSE202565 for differences in gene expression before and after hepatic post-ischemic reperfusion and obtained a total of 53 genes by identifying POCD-related genes. We also screened these 53 genes again and obtained 10 hub genes, which were analyzed and used for correlation prediction. Finally, these 10 hub genes were partially and preliminarily validated using the dataset GSE112713.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>HIRI is closely related to POCD, and reducing the occurrence of HIRI may become one of the ways to avoid or improve postoperative cognitive impairment in the future.</p>
</sec>
</abstract>
<kwd-group>
<kwd>liver ischemia&#x2013;reperfusion injury</kwd>
<kwd>postoperative cognitive dysfunction</kwd>
<kwd>bioinformatics analysis</kwd>
<kwd>drug&#x2013;gene interaction prediction</kwd>
<kwd>miRNA prediction</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Computational Genomics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Postoperative cognitive dysfunction (POCD) refers to a neurocognitive decline after anesthesia and surgery, which constitutes a complication of the central nervous system (CNS) (<xref ref-type="bibr" rid="B28">Rundshagen, 2014</xref>). POCD is clinically characterized by a decrease in cognitive function (learning, memory, thinking, and paying attention) for several days to weeks after surgery, and some patients with POCD may even develop dementia. POCD prolongs patients&#x2019; hospital stay, increases medical costs, and ultimately imposes serious burdens on patients&#x2019; families and society (<xref ref-type="bibr" rid="B13">Gong et al., 2018</xref>; <xref ref-type="bibr" rid="B2">Berger et al., 2015</xref>). POCD is a common postoperative complication that is prevalent among elderly people. With the advancement of medical technology and the aging population in China, an increasing number of elderly patients are undergoing surgery. As a result, the number of patients presenting with POCD is also increasing, a phenomenon that puts enormous economic pressure on the country and their families (<xref ref-type="bibr" rid="B25">Qu et al., 2021</xref>).</p>
<p>Liver transplantation is now widely recognized as the only therapeutic option for end-stage liver disease, acute fulminant liver failure, hepatocellular carcinoma, hilar cholangiocarcinoma, and multiple metabolic disorders (<xref ref-type="bibr" rid="B15">Jadlowiec and Taner, 2016</xref>). The number of patients undergoing liver transplantation is also increasing; however, liver transplantation is inevitably accompanied by hepatic ischemia&#x2013;reperfusion injury (HIRI). HIRI is a complex pathophysiological process involving multiple factors that worsen liver damage, dysfunction, and structural destruction after insufficient or interrupted blood flow to the liver and the subsequent restoration of blood flow (<xref ref-type="bibr" rid="B18">Klune and Tsung, 2010</xref>; <xref ref-type="bibr" rid="B16">Jaeschke, 2003</xref>).</p>
<p>In noncardiac surgery, the frequency of POCD in patients over 60&#xa0;years of age is approximately 20% (<xref ref-type="bibr" rid="B22">Monk et al., 2008</xref>). Some patients are at risk for neurologic complications after undergoing liver transplantation, including embolic stroke, cerebral hemorrhage, and CNS infections, which can lead to varying degrees of cognitive dysfunction (<xref ref-type="bibr" rid="B6">Campagna et al., 2010</xref>). The development of postoperative cognitive dysfunction in liver transplant patients may be related to the development of hepatic ischemia&#x2013;reperfusion injury. <xref ref-type="bibr" rid="B40">Wu et al. (2019)</xref> demonstrated that short-term cognitive dysfunction occurs in a mouse model of hepatic ischemia&#x2013;reperfusion injury. However, there are few studies on the exact mechanism of HIRI-induced POCD. Therefore, in this study, the relationship between POCD and HIRI was investigated using bioinformatics methods (<xref ref-type="fig" rid="F1">Figure 1</xref>), providing a reference for future research on the exact mechanisms linking the two, with the aim of improving or preventing the occurrence of POCD.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Technology roadmap: the overall design thinking for this study.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g001.tif">
<alt-text content-type="machine-generated">Flowchart detailing the analysis of gene expression related to hepatic ischemia-reperfusion injury and postoperative cognitive dysfunction. It includes steps like data collection, variance analysis, DEG identification, Go and KEGG analysis, and PPI network construction. The flowchart also describes the use of various software and databases such as GEO2R, VENNY, R software, Cytoscape, GeneMANIA, DGIdb, and miRWalk for data analysis, resulting in the identification and prediction of hub genes and their interactions.</alt-text>
</graphic>
</fig>
</sec>
<sec sec-type="results" id="s2">
<title>2 Results</title>
<sec id="s2-1">
<title>2.1 Differential analysis of HIRI-related genes and mapping of volcanoes</title>
<p>We screened 259 relevant differentially expressed genes (DEGs) for HIRI from the dataset GSE202565 using GEO2R, including 67 upregulated and 192 downregulated genes, and mapped them in a volcano chart (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Volcano chart mapped using 259 HIRI-related DEGs.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g002.tif">
<alt-text content-type="machine-generated">Volcano plot showing gene expression changes in GSE202565 treatment versus normal. The x-axis represents Log2 Fold Change, and the y-axis shows -log10(p-value). Red dots indicate upregulated genes, blue dots indicate downregulated genes, and gray dots represent genes with no significant change.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-2">
<title>2.2 Identification of POCD-related genes and mapping of Venn</title>
<p>After intersecting 2,053 POCD-related genes with 259 HIRI-related DEGs, 53 DEGs of POCD-related genes were obtained with HIRI-related amounts (<xref ref-type="table" rid="T1">Table 1</xref>). Venn diagrams were plotted (<xref ref-type="fig" rid="F3">Figure 3</xref>). It should be noted that in <xref ref-type="table" rid="T1">Table 1</xref>, all extremely small <italic>p</italic>-values are expressed as <italic>p</italic> &#x3c; 0.001 instead of the actual exact <italic>p</italic>-values.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Symbols of DEGs for 53 POCD-related genes, including the corresponding <italic>p</italic>-value, logFC, and POCD-related genes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Symbol</th>
<th align="left">
<italic>p</italic>-value</th>
<th align="left">logFC</th>
<th align="left">Symbol</th>
<th align="left">
<italic>p</italic>-value</th>
<th align="left">logFC</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">IL-6</td>
<td align="left">&#x3c;0.001</td>
<td align="left">4.911963</td>
<td align="left">CCL3</td>
<td align="left">0.00138</td>
<td align="left">2.26188</td>
</tr>
<tr>
<td align="left">TNF</td>
<td align="left">&#x3c;0.001</td>
<td align="left">3.197148</td>
<td align="left">CACNA1H</td>
<td align="left">0.00543</td>
<td align="left">1.569451</td>
</tr>
<tr>
<td align="left">IL-1B</td>
<td align="left">&#x3c;0.001</td>
<td align="left">4.042976</td>
<td align="left">FGF7</td>
<td align="left">&#x3c;0.001</td>
<td align="left">1.907473</td>
</tr>
<tr>
<td align="left">CXCL8</td>
<td align="left">0.002</td>
<td align="left">3.352203</td>
<td align="left">CD8A</td>
<td align="left">0.0202</td>
<td align="left">1.41055</td>
</tr>
<tr>
<td align="left">CCL2</td>
<td align="left">0.0115</td>
<td align="left">2.462572</td>
<td align="left">KLRK1</td>
<td align="left">0.00249</td>
<td align="left">1.432327</td>
</tr>
<tr>
<td align="left">PTGS2</td>
<td align="left">&#x3c;0.001</td>
<td align="left">3.226491</td>
<td align="left">CD69</td>
<td align="left">0.0185</td>
<td align="left">1.924937</td>
</tr>
<tr>
<td align="left">MALAT1</td>
<td align="left">&#x3c;0.001</td>
<td align="left">3.714757</td>
<td align="left">LIF</td>
<td align="left">0.048</td>
<td align="left">2.335665</td>
</tr>
<tr>
<td align="left">LINC02605</td>
<td align="left">0.0195</td>
<td align="left">2.658483</td>
<td align="left">CCL4</td>
<td align="left">0.00112</td>
<td align="left">2.336597</td>
</tr>
<tr>
<td align="left">SELE</td>
<td align="left">0.0414</td>
<td align="left">1.527353</td>
<td align="left">TNFAIP3</td>
<td align="left">0.0397</td>
<td align="left">1.624781</td>
</tr>
<tr>
<td align="left">GSTM1</td>
<td align="left">0.0468</td>
<td align="left">3.095218</td>
<td align="left">BCL2A1</td>
<td align="left">0.00737</td>
<td align="left">1.995958</td>
</tr>
<tr>
<td align="left">LPL</td>
<td align="left">&#x3c;0.001</td>
<td align="left">1.835197</td>
<td align="left">F2RL2</td>
<td align="left">0.0354</td>
<td align="left">1.41437</td>
</tr>
<tr>
<td align="left">CCR5</td>
<td align="left">0.00186</td>
<td align="left">1.338599</td>
<td align="left">TNFAIP8</td>
<td align="left">0.0173</td>
<td align="left">1.587145</td>
</tr>
<tr>
<td align="left">PLAU</td>
<td align="left">0.00266</td>
<td align="left">2.215611</td>
<td align="left">CYP17A1</td>
<td align="left">&#x3c;0.001</td>
<td align="left">&#x2212;1.4054429</td>
</tr>
<tr>
<td align="left">PTX3</td>
<td align="left">0.0209</td>
<td align="left">2.444272</td>
<td align="left">FOXP3</td>
<td align="left">&#x3c;0.001</td>
<td align="left">&#x2212;1.7752286</td>
</tr>
<tr>
<td align="left">CXCL10</td>
<td align="left">&#x3c;0.001</td>
<td align="left">3.632874</td>
<td align="left">CYP2B6</td>
<td align="left">0.00172999999</td>
<td align="left">&#x2212;2.7678</td>
</tr>
<tr>
<td align="left">CCL5</td>
<td align="left">0.00722</td>
<td align="left">1.474243</td>
<td align="left">NQO1</td>
<td align="left">0.00457</td>
<td align="left">&#x2212;1.6504174</td>
</tr>
<tr>
<td align="left">BMP2</td>
<td align="left">0.0377</td>
<td align="left">1.615078</td>
<td align="left">SAA2</td>
<td align="left">0.00711999</td>
<td align="left">&#x2212;1.547296</td>
</tr>
<tr>
<td align="left">NOD2</td>
<td align="left">0.0379</td>
<td align="left">1.602128</td>
<td align="left">SAA1</td>
<td align="left">0.00621999</td>
<td align="left">&#x2212;1.3962247</td>
</tr>
<tr>
<td align="left">BCYRN1</td>
<td align="left">&#x3c;0.001</td>
<td align="left">5.89061</td>
<td align="left">VWF</td>
<td align="left">0.00905000</td>
<td align="left">&#x2212;1.0415559</td>
</tr>
<tr>
<td align="left">CXCL9</td>
<td align="left">0.00697</td>
<td align="left">1.59966</td>
<td align="left">A2M</td>
<td align="left">0.02100000</td>
<td align="left">&#x2212;1.0197812</td>
</tr>
<tr>
<td align="left">IL-7R</td>
<td align="left">&#x3c;0.001</td>
<td align="left">1.771307</td>
<td align="left">JPH1</td>
<td align="left">0.02309999</td>
<td align="left">&#x2212;1.1267352</td>
</tr>
<tr>
<td align="left">NTF3</td>
<td align="left">&#x3c;0.001</td>
<td align="left">1.520565</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Venn chart of HIRI DEGs with &#x201c;POCD-related&#x201d; genes.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g003.tif">
<alt-text content-type="machine-generated">Venn diagram with two overlapping circles. The left circle, labeled &#x22;HIRI&#x22; in blue, contains the number 259. The right circle, labeled &#x22;POCD&#x22; in yellow, contains the number 2053. The overlapping area contains the number 53, representing the intersection of the two sets.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-3">
<title>2.3 GO analysis of HIRI and POCD-related genes</title>
<p>The top 10 results with the smallest <italic>p</italic>-values were selected from the three categories of biological process (BP), cellular component (CC), and molecular function (MF) in the Gene Ontology (GO) analysis and are plotted as bar charts (<xref ref-type="fig" rid="F4">Figure 4</xref>) and bubble charts (<xref ref-type="fig" rid="F5">Figure 5</xref>). From the figures, we can observe that in the BP category, the main enrichment is related to &#x201c;leukocyte migration.&#x201d; CC is mainly enriched in the &#x201c;external side of plasma&#x201d; and &#x201c;endoplasmic reticulum lumen.&#x201d; MF is primarily enriched in &#x201c;cytokine activity&#x201d; and &#x201c;cytokine receptor binding.&#x201d; Previous studies have found that the above processes are all interconnected through an &#x201c;inflammation&#x2013;neurotoxicity axis&#x201d;&#x2014;leukocyte migration mediates the transmission of peripheral inflammation to the brain, plasma membrane molecules (adhesion molecules and receptors) serve as key mediators, and cytokine&#x2013;receptor binding acts as a core signaling hub, ultimately leading to neuroinflammation, synaptic damage, and cognitive decline.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Bar chart plotted against the results of GO analysis for the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g004.tif">
<alt-text content-type="machine-generated">Bar chart displaying gene ontology terms with categories labeled BP (Biological Process), CC (Cellular Component), and MF (Molecular Function). Chart uses color to indicate q-value significance: red for 0.01, purple for 0.02, and blue for 0.03. Each category lists terms such as &#x22;leukocyte migration&#x22; and &#x22;cytokine activity,&#x22; with corresponding counts on the horizontal axis.</alt-text>
</graphic>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Bubble chart plotted against the results of GO analysis for the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g005.tif">
<alt-text content-type="machine-generated">Clustered dot plot showing gene ontology terms across three categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). Each dot represents a term, with GeneRatio on the x-axis and terms on the y-axis. Dot color indicates q-value, ranging from blue (higher q-value) to red (lower q-value). Dot size reflects count, with larger dots representing higher counts. BP terms show high GeneRatio in red, CC terms vary with blue and purple dots, and MF terms primarily appear in red.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-4">
<title>2.4 KEGG analysis of HIRI and POCD-related genes</title>
<p>The top 30 results with the smallest <italic>p</italic>-values in the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis are plotted as bar charts (<xref ref-type="fig" rid="F6">Figure 6</xref>) and bubble charts (<xref ref-type="fig" rid="F7">Figure 7</xref>). From the graphs, we can observe that the analyzed results are mainly enriched in six areas, including &#x201c;cytokine&#x2013;cytokine receptor&#x201d; and &#x201c;viral protein interaction.&#x201d;</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Bar chart plotted against the results of KEGG analysis for the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g006.tif">
<alt-text content-type="machine-generated">Bar chart showing pathways and diseases with their respective counts. The highest counts are for cytokine-cytokine receptor interaction and related pathways. The color gradient from red to blue indicates q-values ranging from 0.001 to 0.004.</alt-text>
</graphic>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Bubble chart plotted against the results of KEGG analysis for the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g007.tif">
<alt-text content-type="machine-generated">Bubble chart showing various biological pathways related to gene ratios and counts. Larger bubbles represent higher counts. The gene ratio increases along the horizontal axis, with pathways like &#x22;Cytokine-cytokine receptor interaction&#x22; having the highest ratio. Q-value is color-coded from blue (low) to red (high).</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-5">
<title>2.5 Construction of the PPI network of HIRI- and POCD-related genes</title>
<p>The construction of the protein&#x2013;protein interaction (PPI) networks for the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref> (<xref ref-type="fig" rid="F8">Figure 8</xref>) showed that 50 of the 53 genes were associated with each other. Among them, the &#x201c;CYP17A1,&#x201d; &#x201c;JPH1,&#x201d; and &#x201c;CACNA1H&#x201d; genes were not associated with other genes.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Construction of the PPI networks for the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g008.tif">
<alt-text content-type="machine-generated">A complex protein interaction network diagram displaying multiple nodes representing proteins connected by lines indicating interactions. Nodes are color-coded and labeled with protein names such as NQO1 and CD5, with connections denoting relationships or functional associations between these proteins.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-6">
<title>2.6 Cytoscape software analysis of PPI networks to screen for hub genes</title>
<p>The CytoHubba application was used to analyze the constructed PPI network in Cytoscape software (<xref ref-type="fig" rid="F9">Figure 9</xref>). The 53 genes were scored using the MCC algorithm, and we chose 10 genes with the highest scores as the hub genes (<xref ref-type="table" rid="T2">Table 2</xref>), namely, &#x201c;chemokine C&#x2013;C motif ligand 2 (<italic>CCL2</italic>),&#x201d; &#x201c;<italic>IL-1B</italic>,&#x201d; &#x201c;<italic>CXCL10</italic>,&#x201d; &#x201c;<italic>CXCL8</italic>,&#x201d; &#x201c;<italic>CCL4</italic>,&#x201d; &#x201c;<italic>TNF</italic>,&#x201d; &#x201c;<italic>IL-6</italic>,&#x201d; &#x201c;<italic>CCL3</italic>,&#x201d; &#x201c;<italic>CCL5</italic>,&#x201d; and &#x201c;<italic>CD8A</italic>.&#x201d;</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>The analysis of the 53 genes in <xref ref-type="table" rid="T1">Table 1</xref> using the MCC algorithm via the CytoHubba function in Cytoscape software yielded hub genes.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g009.tif">
<alt-text content-type="machine-generated">Network diagram showing interactions between cytokines and chemokines. Nodes represent molecules labeled CCL5, CXCL10, CCL3, CCL2, CXCL8, IL6, CD8A, CCL4, TNF, and IL1B, interconnected by lines indicating relationships. Node colors range from yellow to red.</alt-text>
</graphic>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>The 53 genes in <xref ref-type="table" rid="T1">Table 1</xref> were scored using the MCC algorithm via the CytoHubba function in Cytoscape software.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Rank</th>
<th align="left">Name</th>
<th align="left">Score</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">IL-1B</td>
<td align="left">444821169001104</td>
</tr>
<tr>
<td align="left">1</td>
<td align="left">IL-6</td>
<td align="left">444821169001104</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">TNF</td>
<td align="left">444821169001086</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">CXCL8</td>
<td align="left">444821165371441</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">CCL2</td>
<td align="left">444821165002920</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">CXCL10</td>
<td align="left">444821164220160</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">CCL5</td>
<td align="left">444821163857280</td>
</tr>
<tr>
<td align="left">8</td>
<td align="left">CCL3</td>
<td align="left">444821003832240</td>
</tr>
<tr>
<td align="left">9</td>
<td align="left">CCL4</td>
<td align="left">444821003827200</td>
</tr>
<tr>
<td align="left">10</td>
<td align="left">CD8A</td>
<td align="left">444796099817042</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-7">
<title>2.7 Hub gene GO analysis</title>
<p>The top 10 results with the smallest <italic>p</italic>-values were selected from the three categories of BP, CC, and MF in the GO analysis and are plotted as bar charts (<xref ref-type="fig" rid="F10">Figure 10</xref>) and bubble charts (<xref ref-type="fig" rid="F11">Figure 11</xref>). From the graphs, it can be found that in BP, the main enrichment involves four aspects, including &#x201c;leukocyte migration.&#x201d; CC is mainly enriched in four aspects, including the &#x201c;external side of plasma.&#x201d; MF was enriched primarily in four areas, including growth factor receptor binding, cytokine activity, and cytokine receptor binding.</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Bar chart plotted against the results of GO analysis for the hub gene.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g010.tif">
<alt-text content-type="machine-generated">Bar chart divided into three panels representing biological processes (BP), cellular components (CC), and molecular functions (MF). BP shows highest counts in leukocyte migration and neutrophil chemotaxis. CC highlights the external side of the plasma membrane and membrane raft. MF emphasizes cytokine activity and receptor binding. q-values range from 0.03 to 0.09, with color coding from red to blue.</alt-text>
</graphic>
</fig>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption>
<p>Bubble chart plotted against the results of GO analysis for the hub gene.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g011.tif">
<alt-text content-type="machine-generated">Bubble chart depicting gene ontology enrichment analysis across three categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). Dots indicate gene ratio, colored by significance (q-value) from red (more significant) to blue. Dot size represents count, ranging from 2.5 to 7.5. Prominent terms in BP include leukocyte migration; in CC, external side of plasma membrane; in MF, cytokine activity.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-8">
<title>2.8 KEGG analysis of the hub gene</title>
<p>The results of the KEGG analysis with the top 30 <italic>p</italic>-values were selected and are plotted as a bar graph (<xref ref-type="fig" rid="F12">Figure 12</xref>) and a bubble graph (<xref ref-type="fig" rid="F13">Figure 13</xref>). From the graphs, it can be observed that there are four main areas of enrichment, including &#x201c;cytokine&#x2013;cytokine receptor&#x201d;.</p>
<fig id="F12" position="float">
<label>FIGURE 12</label>
<caption>
<p>Bar chart plotted against the results of KEGG analysis for the hub gene.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g012.tif">
<alt-text content-type="machine-generated">Horizontal bar chart displaying various pathways and diseases sorted by count, with corresponding Q-values indicated by color. The top items include &#x22;Viral protein interaction with cytokine and cytokine receptor&#x22; and &#x22;Toll-like receptor signaling pathway.&#x22; The color gradient ranges from red to blue, representing Q-values from 1e-05 to 5e-05.</alt-text>
</graphic>
</fig>
<fig id="F13" position="float">
<label>FIGURE 13</label>
<caption>
<p>Bubble chart plotted against the results of KEGG analysis for the hub gene.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g013.tif">
<alt-text content-type="machine-generated">Bubble plot depicting gene set enrichment analysis. The x-axis represents the Gene Ratio, and the y-axis lists biological processes and diseases, such as cytokine-cytokine receptor interaction and rheumatoid arthritis. Bubble sizes indicate gene count, and colors represent q-values, with a gradient from blue (high q-value) to red (low q-value). The plot highlights pathways like IL-17 signaling and coronavirus disease.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-9">
<title>2.9 Reciprocal prediction between genes</title>
<p>The inter-gene prediction of the screened 10 hub genes (<xref ref-type="fig" rid="F14">Figure 14</xref>) showed that 58 genes were interrelated with these 10 hub genes.</p>
<fig id="F14" position="float">
<label>FIGURE 14</label>
<caption>
<p>Prediction of gene interactions on hub genes.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g014.tif">
<alt-text content-type="machine-generated">Network diagram of protein interactions with nodes labeled by gene symbols like TNF, IL6, and CXCL8. Multicolored lines indicate types of interactions, detailed in a legend showing co-expression, shared domains, and others. Functions like cytokine activity and chemokine response are also listed, each with a color code.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-10">
<title>2.10 Reciprocal prediction between genes and drugs</title>
<p>After drug&#x2013;drug interactions were predicted for the screened hub genes (<xref ref-type="fig" rid="F15">Figure 15</xref>), the results showed that 7 genes had interactions with drugs, including a total of 17 medications associated with TNF, 17 drugs acting on IL-6, 12 drugs acting on CXCL8, 11 drugs acting on CXCL10, 3 drugs acting on CCL4, and 1 drug each acting on CCL3 and CCL5. There is one drug that acts on both TNF and IL-6.</p>
<fig id="F15" position="float">
<label>FIGURE 15</label>
<caption>
<p>Prediction of drug&#x2013;gene interactions on hub genes.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g015.tif">
<alt-text content-type="machine-generated">Network diagram displaying interactions between proteins (TNF, IL6, CXCL8, CXCL10, CCL4) and various drugs. Each protein is represented by a blue oval connected by lines to drug names in yellow-bordered ovals, indicating possible relationships or effects.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-11">
<title>2.11 miRNA prediction of hub genes</title>
<p>Further screening of the microRNA (miRNA) prediction results of the 10 hub genes screened (<xref ref-type="fig" rid="F16">Figure 16</xref>) showed that ten miRNAs might be regulated by CCL5, four by CXCL8, three by CXCL10, two by TNF, one by CCL4, and one by IL-1B. IL-1B may be regulated by one miRNA, whereas TNF and CCL5 may share a common miRNA.</p>
<fig id="F16" position="float">
<label>FIGURE 16</label>
<caption>
<p>miRNA expression prediction on hub genes.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g016.tif">
<alt-text content-type="machine-generated">Network diagram showing interactions between blue nodes labeled TNF, CCL5, CXCL8, CXCL10, CCL4, and IL1B, and red nodes labeled with various hsa-miR identifiers. Arrows indicate the relationships between them.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-12">
<title>2.12 Initial validation of the hub gene</title>
<p>After differential analysis and volcano plotting of the dataset GSE112713 (<xref ref-type="fig" rid="F17">Figure 17</xref>), the results showed 166 DEGs, including 161 upregulated genes and 5 downregulated genes. Compared with the 2,053 genes in the POCD-related genes, 51 were initially validated, including <italic>HSPA1A</italic>, <italic>CD83</italic>, <italic>HBEGF</italic>, <italic>KLF5</italic>, and <italic>CALCA</italic>. Comparing with 53 genes in <xref ref-type="table" rid="T1">Table 1</xref>, 9 of them were preliminarily validated, namely, <italic>TNFAIP3</italic>, <italic>PTGS2</italic>, <italic>LIF</italic>, <italic>BMP2</italic>, <italic>PTX3</italic>, <italic>IL-6</italic>, <italic>CCL2</italic>, <italic>IL1-B</italic>, and <italic>CCL3</italic>. Compared with 10 hub genes screened in <xref ref-type="table" rid="T2">Table 2</xref>, <italic>IL-6</italic>, <italic>CCL2</italic>, <italic>IL1-B</italic>, and <italic>CCL3</italic> were preliminarily validated (<xref ref-type="fig" rid="F18">Figure 18</xref>).</p>
<fig id="F17" position="float">
<label>FIGURE 17</label>
<caption>
<p>Volcano chart mapped using 166 HIRI-related DEGs.</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g017.tif">
<alt-text content-type="machine-generated">Volcano plot titled &#x22;GSE112713 post vs pre&#x22; representing gene expression data. The x-axis shows Log2 Fold Change and the y-axis displays negative Log10 p-value. Red dots indicate upregulated genes, blue dots indicate downregulated genes, and gray dots show non-significant changes. Most blue dots are clustered on the left, indicating numerous downregulated genes.</alt-text>
</graphic>
</fig>
<fig id="F18" position="float">
<label>FIGURE 18</label>
<caption>
<p>Venn chart of &#x201c;POCD,&#x201d; &#x201c;<xref ref-type="table" rid="T1">Table 1</xref>&#x201d; &#x201c;GSE112713,&#x201d; and &#x201c;hub gene.&#x201d;</p>
</caption>
<graphic xlink:href="fgene-16-1607446-g018.tif">
<alt-text content-type="machine-generated">Venn diagram showing the distribution of items across four categories: POCD, Hub, GSE112713, and Table1. Each category is represented in an overlapping multicolored area, with the largest numbers in POCD, including 2011 items (90.5%) exclusive to it. Other intersections show varying smaller percentages, with some intersections having no items.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s3">
<title>3 Discussion</title>
<p>HIRI has been the focus of several studies in recent years due to its role in various clinical situations. With the implementation of vascular surgical techniques in liver surgery, HIRI is recognized as a key contributor to postoperative morbidity and mortality (<xref ref-type="bibr" rid="B16">Jaeschke, 2003</xref>) because it not only causes liver dysfunction but also damages distant organs, especially the brain (<xref ref-type="bibr" rid="B23">Na et al., 2014</xref>; <xref ref-type="bibr" rid="B35">Tong et al., 2018</xref>; <xref ref-type="bibr" rid="B17">Jochmans et al., 2017</xref>).</p>
<p>Previous studies have demonstrated that hepatic ischemia&#x2013;reperfusion injury can induce damage to distant organs, including the hippocampus and cortex, through activation of NLRP3 inflammatory vesicles and neuronal focal death (<xref ref-type="bibr" rid="B46">Zhang et al., 2019</xref>). It has also been suggested that abnormal mitochondrial dynamics may be a potential mechanism for HIRI-induced hippocampal injury and cognitive dysfunction (<xref ref-type="bibr" rid="B44">Yu et al., 2020</xref>). However, the specific mechanism of cognitive dysfunction caused by HIRI remains unclear. Therefore, this study theoretically investigated the relationship between HIRI and POCD through bioinformatics analysis.</p>
<p>Our study shows that the expression of relevant gene levels in the liver after a period of ischemia is significantly different before and after reperfusion. We defined the genes that satisfy <italic>p</italic>-value &#x3c; 0.05 and &#x7c;logFC&#x7c; &#x2265; 1 as DEGs. These DEGs determine the proteins with differential expression. It can be found from the volcano plot in <xref ref-type="fig" rid="F1">Figure 1</xref> that the vast majority of these DEGs are downregulated genes. So, we believe that the differentially expressed proteins encoded by DEGs may be one of the causes of HIRI. Among these DEGs, 53 were POCD-related genes (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Previous studies have found that these 53 genes are involved in the occurrence and development of cognitive dysfunction through multiple mechanisms, mainly including neuroinflammation, immune cell infiltration, blood&#x2013;brain barrier (BBB) damage, and oxidative stress. Among these POCD-related genes, 3 genes had correlation scores of 20 or more, 6 genes had correlation scores of 10 or more, and 13 genes had correlation scores of 5 or more. Although there were also genes with correlation scores below 5, they provided us with the necessary conditions to further validate POCD and HIRI. In the PPI network constructed for these 53 genes (<xref ref-type="fig" rid="F8">Figure 8</xref>), there was a strong expression linkage between the genes, but the <italic>CYP17A1</italic>, <italic>JPH1</italic>, and <italic>CACNA1H</italic> genes were not linked to the other genes and thus could be used as targets for elimination in subsequent studies. We analyzed the PPI network again using statistical methods (<xref ref-type="fig" rid="F8">Figure 8</xref>), narrowed it down to screen again (<xref ref-type="fig" rid="F9">Figure 9</xref>), and screened out 10 hub genes (<xref ref-type="table" rid="T2">Table 2</xref>). The GO analysis of the 10 hub genes (<xref ref-type="fig" rid="F12">Figure 12</xref>), along with KEGG analysis (<xref ref-type="fig" rid="F13">Figure 13</xref>), provides an important basis for our future research. In the protein interaction prediction of hub genes, 53 genes interacted were identified, which were co-expressed in some aspects, which provides direction for our subsequent studies. We applied the research data to the dataset GSE112713 for preliminary validation of our study. As shown in <xref ref-type="fig" rid="F18">Figure 18</xref>, the POCD-related genes in this dataset overlap with the 53 genes we screened in <xref ref-type="table" rid="T1">Table 1</xref> and contain 4 of the hub genes we screened. The results further suggest that POCD plays an important role in HIRI with these 10 genes.</p>
<p>CCL2, also known as monocyte chemoattractant protein 1 (MCP-1), is a member of the CC subtype chemokine family and acts through its cognate receptor, chemokine receptor 2 (CCR2) (<xref ref-type="bibr" rid="B4">Bose and Cho, 2013</xref>). CCL2 expression is elevated in a variety of diseases characterized by acute and chronic inflammation (<xref ref-type="bibr" rid="B8">Cerri et al., 2016</xref>). Moreover, HIRI leads to a severe inflammatory response in the body. It has been previously shown that surgically induced upregulation of CCL2 expression in activated astrocytes promotes microglia activation and M1 polarization, increasing pro-inflammatory cytokines and hippocampal neuronal damage (<xref ref-type="bibr" rid="B41">Xu et al., 2017</xref>). In HIRI, CCL2 expression shows a significant upregulation and is considered an important DEG (<xref ref-type="bibr" rid="B45">Zhang et al., 2016</xref>). In a comprehensive study on gene microarray analysis of expression profiles in HIRI (<xref ref-type="bibr" rid="B48">Zheng et al., 2017</xref>), it has been shown that CCL2 is an upregulated DEG. This study reveals that CCL2 may play an important role in HIRI with potential clinical implications. In our research, CCL2 was the hub gene, so we hypothesized that CCL2 plays an important role in HIRI-induced POCD.</p>
<p>Interleukin-1B (IL-1B) is a potent pro-inflammatory cytokine essential for host defense responses against infection and injury (<xref ref-type="bibr" rid="B19">Lopez-Castejon and Brough, 2011</xref>). IL-1B is required for the induction of CCL2 (<xref ref-type="bibr" rid="B5">Burke et al., 2012</xref>). In a bioinformatics analysis of the pathogenesis of postoperative cognitive dysfunction (<xref ref-type="bibr" rid="B3">Bhuiyan et al., 2022</xref>), IL-1B was found to play an important role. In our study, CCL2 and IL-1B were screened as hub genes in the bioinformatics analysis of HIRI leading to POCD; they were intricately related in the predicted PPI network&#x2013;gene interactions, and when scored using the CytoHubba functional MCC algorithm in Cytoscape software, both CCL2 and IL-1B received equally high scores. Meanwhile, the correlation scores of CCL2 and IL-1B in the GeneCards database were 18 and 27, respectively, ranking 66th and 22nd among all 2,106 genes. Therefore, we can hypothesize that CCL2 and IL-1B play very important roles in POCD caused by HIRI. In addition, a study analyzing potential immune-related genes involved in the pathogenesis of ischemia&#x2013;reperfusion injury after liver transplantation identified nine genes (<xref ref-type="bibr" rid="B14">Guo et al., 2023</xref>), two of which&#x2014;CCL4 and CXCL8&#x2014;were also among the hub genes predicted in our study. CXCL8 has a correlation score of 18.8 in the GeneCards database, thus reinforcing that HIRI leads to the development of POCD.</p>
<p>How to mitigate or prevent the occurrence of POCD after HIRI has been the focus of research in clinical work and is also the most important concern of clinical staff. HIRI is one of the causes of POCD, and inhibition of HIRI can alleviate the occurrence of POCD. Some studies have shown (<xref ref-type="bibr" rid="B40">Wu et al., 2019</xref>) that rats with a short duration of liver ischemia&#x2013;reperfusion exhibit less cognitive impairment than those with a longer ischemia duration. However, there are fewer studies on pharmacologic aspects. Therefore, we surveyed the related elements and predicted drug&#x2013;gene interactions for the 10 hub genes we screened; these predicted drugs can provide a reference for the targeted treatment of POCD in future clinical work.</p>
<p>miRNAs, which are non-coding RNAs approximately 21 nucleotides long, are key post-transcriptional regulators of gene expression in postnatal animals, plants, and protozoa. In mammals, miRNAs are predicted to control the activity of more than 60% of all protein-coding genes (<xref ref-type="bibr" rid="B12">Friedman et al., 2009</xref>). It has very powerful physiological roles in fine regulation of gene expression, controlling early development, cell proliferation, apoptosis, cell death, lipid metabolism, and cell differentiation, which directly affect tissues, organs, and even our entire system (<xref ref-type="bibr" rid="B30">Saliminejad et al., 2019</xref>). miRNAs play an essential role in regulating the translation and transcription of genes in various ways, such as target mRNA degradation and inhibition of target gene translation (<xref ref-type="bibr" rid="B42">Yazit et al., 2020</xref>). miRNAs also play important roles in developing the nervous system, memory, and learning and can potentially cause neurological disorders (<xref ref-type="bibr" rid="B36">Wei et al., 2017</xref>). A study has demonstrated that miR-181b-5p can attenuate early POCD by suppressing hippocampal neuroinflammation in mice (<xref ref-type="bibr" rid="B20">Lu et al., 2019</xref>). In this study, the prediction of related miRNA expression of 10 hub genes (<xref ref-type="fig" rid="F16">Figure 16</xref>) further revealed the relationship between HIRI and POCD, which can be used to study the specific mechanism by which HIRI leads to POCD and may provide new ideas for mitigating the occurrence of POCD in clinical work. The miRNAs analyzed in this study were compared with those identified in a bioinformatics analysis investigating the role of ferroptosis (iron-dependent cell death) in hepatic ischemia&#x2013;reperfusion injury (<xref ref-type="bibr" rid="B33">Sun et al., 2022</xref>). The miRNAs predicted in this study showed both similarities and differences. For the hsa-miRNA-24-3p that we predicted, there was a study that showed that the use of rosuvastatin alleviated ischemia/reperfusion injury in cardiomyocytes by downregulating hsa-miR-24-3p to target the upregulated uncoupling protein 2 (UCP2) (<xref ref-type="bibr" rid="B37">Wei et al., 2019</xref>). Our study predicted has-miRNA-34a-5p, with studies confirming that miR-34a-5p may protect the liver from ischemia/reperfusion injury by inhibiting the JNK/P38 signaling pathway through the downregulation of hepatocyte nuclear factor 4&#x3b1; (HNF4&#x3b1;) (<xref ref-type="bibr" rid="B47">Zheng et al., 2022</xref>). Therefore, we hypothesized that regulating miRNA levels may attenuate the occurrence of postoperative cognitive impairment by alleviating HIRI.</p>
<p>Although we have conducted extensive research on the correlation between HIRI and POCD, this study still has some limitations. First, we have only used human genes to hypothesize the relationship between HIRI and POCD and have not studied it in animals. In addition, we analyzed HIRI and POCD using only theory, but the biological functions and roles of related genes need to be further investigated by <italic>in vivo</italic> modeling. Finally, there are some limitations in our data selection. We only selected HIRI in liver transplantation and could not include all the conditions leading to HIRI. Therefore, these situations are the focus of our future research and discussion, and we need to refine the relevant experiments to corroborate the conclusions we have hypothesized. Despite the limitations, our findings provide preliminary clues to investigate the relationship between HIRI and POCD and improve and prevent the occurrence of postoperative cognitive impairment in patients.</p>
</sec>
<sec sec-type="materials|methods" id="s4">
<title>4 Materials and methods</title>
<sec id="s4-1">
<title>4.1 Data sources</title>
<p>The Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) is a public gene expression database created by the National Center for Biotechnology Information (NCBI). A public gene expression database contains high-throughput gene expression data and microarray gene expression data (<xref ref-type="bibr" rid="B11">Edgar et al., 2002</xref>). We selected the GSE202565 dataset from this database for bioinformatics analysis of genes related to POCD. The GSE202565 dataset is from a study on the administration of the irreversible pan-cysteine asparaginase inhibitor during ambient machine perfusion of the liver, which attenuates innate immune and pro-inflammatory responses in a non-<italic>in-situ</italic> environment. We chose to include a set of data: eleven livers from a study cohort of human livers discarded after prior machine perfusion served as the control group and five consecutively recruited human livers rejected for transplantation served as the experimental group, which received emricasan at a dose of 5&#xa0;mg/kg liver weight before the start of hepatic perfusion. Empty core needle biopsies for transcriptome sequencing were performed before perfusion and 3 and 6&#xa0;h after perfusion (<xref ref-type="bibr" rid="B26">Raigani et al., 2022</xref>).</p>
<p>The GeneCards database is a comprehensive and authoritative compendium of annotated information on human genes that, and it has been widely used for nearly 15&#xa0;years. Its gene-centered content is automatically mined and integrated from over 80 digital sources (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org">www.genecards.org</ext-link>) (<xref ref-type="bibr" rid="B29">Safran et al., 2010</xref>). This database is comprehensive, aiming to provide comprehensive information on the human genome. It integrates a large number of data sources worldwide, including genomics, transcriptomics, proteomics, genetics, clinical, and functional information. We downloaded genes related to postoperative cognitive dysfunction from this database and obtained 2,053 POCD-related genes.</p>
</sec>
<sec id="s4-2">
<title>4.2 Bioinformatics analysis methods</title>
<sec id="s4-2-1">
<title>4.2.1 Differential analysis of HIRI-related genes and mapping of volcanoes</title>
<p>We selected data with a reperfusion time of 3&#xa0;h from the GSE202565 dataset as samples. The selected samples were subjected to differential analysis of gene expression data before and after liver reperfusion using the GEO2R online tool (<xref ref-type="bibr" rid="B1">Barrett et al., 2012</xref>) in the GEO database. We plotted a volcano plot with a <italic>p</italic>-value &#x3c; 0.05 and &#x7c;logFC&#x7c; &#x2265; 1 as a condition.</p>
</sec>
<sec id="s4-2-2">
<title>4.2.2 Acquisition of POCD-related genes and mapping of Venn</title>
<p>We searched the GeneCards database using the search term POCD and obtained 2,053 POCD-related genes; these genes were further analyzed using the VENNY website (version: 2.1) (<ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>) (<xref ref-type="bibr" rid="B24">Oliveros, 2022</xref>). The obtained DEGs of HIRI and POCD-related genes were taken as intersections and plotted in Venn plots.</p>
</sec>
<sec id="s4-2-3">
<title>4.2.3 GO and KEGG analyses</title>
<p>GO enrichment analysis is a commonly used bioinformatics method for searching large-scale genetic data (including BP, CC, and MF) for comprehensive information. KEGG pathway enrichment analysis is widely used to understand the biological mechanisms and functions of genes/proteins in biological processes (<xref ref-type="bibr" rid="B10">Dong et al., 2021</xref>).</p>
<p>We obtained the intersecting genes between the HIRI- and POCD-related DEGs described above using R software (version: 4.3.1) and the following packages: clusterProfiler (version: 4.4.4) (<xref ref-type="bibr" rid="B27">R Core Team, 2022</xref>) (<xref ref-type="bibr" rid="B39">Wu et al., 2021</xref>), org.Hs.eg.db (version: 3.15.0) (<xref ref-type="bibr" rid="B21">Marc, 2022</xref>), enrichplot (version: 1.16.2) (<xref ref-type="bibr" rid="B43">Yu, 2022</xref>), and ggplot2 (version: 3.3.6) (<xref ref-type="bibr" rid="B38">Wickham, 2016</xref>). The KEGG and GO analyses were performed using a p-value &#x3c;0.05. The obtained results of GO and KEGG analyses were sorted in order from smallest to largest, and the top 10 results of the selected GO analysis and the top 30 results of KEGG analysis were plotted as bar charts and bubble charts, respectively.</p>
</sec>
<sec id="s4-2-4">
<title>4.2.4 Constructing protein&#x2013;protein interaction networks</title>
<p>The STRING database (version: 11.5) (<ext-link ext-link-type="uri" xlink:href="https://cn.string-db.org/">https://cn.string-db.org/</ext-link>) is a systematic collection and integration of protein&#x2013;protein interactions, including physical interactions and functional associations (<xref ref-type="bibr" rid="B34">Szklarczyk et al., 2023</xref>). We put the DEGs of HIRI and the intersecting genes obtained from POCD-related genes into this database for PPI network construction.</p>
</sec>
<sec id="s4-2-5">
<title>4.2.5 Cytoscape software to analyze PPI networks and screen hub genes</title>
<p>Cytoscape software (version 3.9.1) graphically displays, analyzes, and edits networks (<xref ref-type="bibr" rid="B31">Shannon et al., 2003</xref>). We used the CytoHubba application within Cytoscape to analyze the PPI network and applied the widely used MCC algorithm to screen for hub genes (<xref ref-type="bibr" rid="B9">Chin et al., 2014</xref>).</p>
</sec>
<sec id="s4-2-6">
<title>4.2.6 Hub gene GO and KEGG analyses</title>
<p>The screened hub genes were subjected to GO and KEGG analyses again in the same way as described in <xref ref-type="sec" rid="s2-3">Section 2.3</xref>. Bubble and bar graphs were also obtained.</p>
</sec>
<sec id="s4-2-7">
<title>4.2.7 Prediction of inter-gene interactions</title>
<p>The GeneMANIA database (<ext-link ext-link-type="uri" xlink:href="http://genemania.org/">http://genemania.org/</ext-link>) can help predict gene interactions (<xref ref-type="bibr" rid="B10">Dong et al., 2021</xref>). We can use this database to predict interactions between genes related to hub genes.</p>
</sec>
<sec id="s4-2-8">
<title>4.2.8 Prediction of drug&#x2013;gene interactions</title>
<p>The DGIdb database (version: 4.2.0) (<ext-link ext-link-type="uri" xlink:href="https://www.dgidb.org/">https://www.dgidb.org/</ext-link>) is a publicly accessible resource that compiles information on genes or gene products, drugs, and drug&#x2013;gene interactions (<xref ref-type="bibr" rid="B7">Cannon et al., 2024</xref>). We use this database to predict drugs with which hub genes are associated. The resulting data were screened under the conditions of registration approval status as approved and an interaction score of 10. The screened data were visualized using Cytoscape software (version 3.9.1).</p>
</sec>
<sec id="s4-2-9">
<title>4.2.9 miRNA prediction</title>
<p>The Norwalk database (version 2.0) (<ext-link ext-link-type="uri" xlink:href="http://mirwalk.umm.uni-heidelberg.de/">http://mirwalk.umm.uni-heidelberg.de/</ext-link>) enables the prediction of interactions between genes and miRNAs (<xref ref-type="bibr" rid="B32">Sticht et al., 2018</xref>). We used this database for the correlation prediction of miRNA expression of hub genes, further filtered the results using validated as a filtering condition, and finally visualized them using Cytoscape software (version: 3.9.1).</p>
</sec>
<sec id="s4-2-10">
<title>4.2.10 Initial validation of the hub gene</title>
<p>We selected the dataset GSE112713 from the GEO database for initial validation of the previously screened hub genes. The GSE112723 dataset is from a study on ambient machine perfusion to inhibit pro-inflammatory responses and promote liver regeneration. We selected one of the datasets: liver transplant patients; transplanted liver donors were preserved using the traditional cold storage method, and liver tissues were extracted for microarray gene expression analysis at the end of the preservation before reperfusion and 60&#xa0;min after reperfusion, with a total of 11 sets of samples (<xref ref-type="bibr" rid="B33">Sun et al., 2022</xref>). A total of 11 sample sets were analyzed using GEO2R in the GEO database (<xref ref-type="bibr" rid="B1">Barrett et al., 2012</xref>) to identify difference expression; volcano plots were generated using a <italic>p</italic>-value &#x3c; 0.05 and &#x7c;logFC&#x7c; &#x2265; 1. Finally, the genes related to POCD, the genes in <xref ref-type="table" rid="T1">Table 1</xref>, and the hub genes were analyzed using the VENNY website (version: 2.1) (<ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>) (<xref ref-type="bibr" rid="B24">Oliveros, 2022</xref>). Online Venn plots were drawn for preliminary validation of hub genes.</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>Liver ischemia&#x2013;reperfusion is one of the leading causes of liver injury in liver surgery. It can severely impair the cognitive function of patients in the postoperative period. This study shows that 53 DEGs and hub genes associated with HIRI, screened using bioinformatics methods, were closely related to POCD. The bioinformatics method of analyzing these genes helps further reveal the relevant mechanisms of HIRI leading to postoperative cognitive impairment. It provides valuable reference information for future in-depth research by other investigators. The targeted drugs and miRNAs predicted for the 10 hub genes provide reference value for clinical efforts to reduce the incidence of cognitive impairment after liver surgery and lessen the economic burden on patients. The 10 hub genes can be used as therapeutic targets for POCD and become essential resources for future research on the pathogenesis, diagnosis, and therapeutic intervention of POCD.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/supplementary material.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>QH: conceptualization, formal analysis, data curation, writing &#x2013; original draft, and writing &#x2013; review and editing. HL: writing &#x2013; review and editing and validation. YB: methodology and writing &#x2013; review and editing. ZF: investigation and writing &#x2013; review and editing. HZ: writing &#x2013; review and editing and formal analysis. JL: conceptualization, writing &#x2013; review and editing, formal analysis, and data curation.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work has been funded by the Hebei provincial government, the medical research project of Hebei Province, and the scientific and technological research and development plan of Chengde City, Hebei Province.</p>
</sec>
<ack>
<p>This work was supported by the Medical Science Research Project of Hebei Province.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wilhite</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Ledoux</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Evangelista</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>I. F.</given-names>
</name>
<name>
<surname>Tomashevsky</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>NCBI GEO: archive for functional genomics data sets&#x2014;update</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume> (<issue>D1</issue>), <fpage>D991</fpage>&#x2013;<lpage>D995</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nadler</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Browndyke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Terrando</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ponnusamy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>H. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Postoperative cognitive dysfunction: minding the gaps in our knowledge of a common postoperative complication in the elderly</article-title>. <source>Anesthesiol. Clin.</source> <volume>33</volume> (<issue>3</issue>), <fpage>517</fpage>&#x2013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1016/j.anclin.2015.05.008</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhuiyan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chuwdhury</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>F. F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Network biology approaches to uncover therapeutic targets associated with molecular signaling pathways from circRNA in postoperative cognitive dysfunction pathogenesis</article-title>. <source>J. Mol. Neurosci.</source> <volume>72</volume> (<issue>9</issue>), <fpage>1875</fpage>&#x2013;<lpage>1901</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-022-02042-6</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases</article-title>. <source>Archives pharmacal Res.</source> <volume>36</volume>, <fpage>1039</fpage>&#x2013;<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1007/s12272-013-0161-z</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burke</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Updegraff</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Minkin</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Biggerstaff</surname>
<given-names>J. P.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Regulation of the CCL2 gene in pancreatic &#x3b2;-cells by IL-1&#x3b2; and glucocorticoids: role of MKP-1</article-title>. <source>PLoS One</source> <volume>7</volume>, <fpage>e46986</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0046986</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campagna</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Biancardi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cillo</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gatta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Amodio</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Neurocognitive-neurological complications of liver transplantation: a review</article-title>. <source>Metab. Brain Dis.</source> <volume>25</volume>, <fpage>115</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-010-9183-0</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Coffman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kiwala</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>DGIdb 5.0: rebuilding the drug&#x2013;gene interaction database for precision medicine and drug discovery platforms</article-title>. <source>Nucleic Acids Res.</source> <volume>52</volume> (<issue>D1</issue>), <fpage>D1227</fpage>&#x2013;<lpage>D1235</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkad1040</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Genovesi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Allegra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pistillo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>P&#xfc;ntener</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Guglielmotti</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The chemokine CCL2 mediates the seizure-enhancing effects of systemic inflammation</article-title>. <source>J. Neurosci.</source> <volume>36</volume> (<issue>13</issue>), <fpage>3777</fpage>&#x2013;<lpage>3788</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0451-15.2016</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chin</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.-H.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>cytoHubba: identifying hub objects and sub-networks from complex interactome</article-title>. <source>BMC Syst. Biol.</source> <volume>8</volume> (<issue>S4</issue>), <fpage>S11</fpage>. <pub-id pub-id-type="doi">10.1186/1752-0509-8-S4-S11</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension</article-title>. <source>Aging (Albany NY)</source> <volume>13</volume> (<issue>10</issue>), <fpage>14234</fpage>&#x2013;<lpage>14257</lpage>. <pub-id pub-id-type="doi">10.18632/aging.203040</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Domrachev</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lash</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Gene expression omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume> (<issue>1</issue>), <fpage>207</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Farh</surname>
<given-names>K. K. H.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Most Mammalian mRNAs are conserved targets of microRNAs</article-title>. <source>Genome Res.</source> <volume>19</volume> (<issue>1</issue>), <fpage>92</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1101/gr.082701.108</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>B. Q.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Z. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Postoperative cognitive dysfunction induced by different surgical methods and its risk factors</article-title>. <source>Am. Surg.</source> <volume>84</volume> (<issue>9</issue>), <fpage>1531</fpage>&#x2013;<lpage>1537</lpage>. <pub-id pub-id-type="doi">10.1177/000313481808400963</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation</article-title>. <source>Front. Immunol.</source> <volume>14</volume>, <fpage>1126497</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1126497</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jadlowiec</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Taner</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Liver transplantation: current status and challenges</article-title>. <source>World J. gastroenterology</source> <volume>22</volume> (<issue>18</issue>), <fpage>4438</fpage>&#x2013;<lpage>4445</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v22.i18.4438</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaeschke</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning</article-title>. <source>Am. J. Physiology-Gastrointestinal Liver Physiology</source> <volume>284</volume> (<issue>1</issue>), <fpage>G15</fpage>&#x2013;<lpage>G26</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00342.2002</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jochmans</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Meurisse</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Neyrinck</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Verhaegen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Monbaliu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pirenne</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Hepatic ischemia/reperfusion injury associates with acute kidney injury in liver transplantation: prospective cohort study</article-title>. <source>Liver Transplant.</source> <volume>23</volume> (<issue>5</issue>), <fpage>634</fpage>&#x2013;<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1002/lt.24728</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klune</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Tsung</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements</article-title>. <source>Surg. Clin. N. Am.</source> <volume>90</volume> (<issue>4</issue>), <fpage>665</fpage>&#x2013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1016/j.suc.2010.04.003</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Castejon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brough</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Understanding the mechanism of IL-1&#x3b2; secretion</article-title>. <source>Cytokine and growth factor Rev.</source> <volume>22</volume> (<issue>4</issue>), <fpage>189</fpage>&#x2013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2011.10.001</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice</article-title>. <source>Cytokine</source> <volume>120</volume>, <fpage>41</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2019.04.005</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marc</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Org. Hs. eg. db: genome wide annotation for human</article-title>. <source>R. Package Version</source> <volume>3.15.0</volume>. <pub-id pub-id-type="doi">10.18129/B9.bioc.org.Hs.eg.db</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monk</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Weldon</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Garvan</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Dede</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>van der Aa</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Heilman</surname>
<given-names>K. M.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Predictors of cognitive dysfunction after major noncardiac surgery</article-title>. <source>J. Am. Soc. Anesthesiol.</source> <volume>108</volume> (<issue>1</issue>), <fpage>18</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/01.anes.0000296071.19434.1e</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nastos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kalimeris</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Papoutsidakis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tasoulis</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Lykoudis</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Theodoraki</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Global consequences of liver ischemia/reperfusion injury</article-title>. <source>Oxidative Med. Cell. Longev.</source> <volume>2014</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1155/2014/906965</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveros</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>An interactive tool for comparing lists with Venn&#x27;s diagrams</article-title>.</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The neuroprotection of deproteinized calf blood extractives injection against Alzheimer&#x27;s disease <italic>via</italic> regulation of Nrf-2 signaling</article-title>. <source>Aging (Albany NY)</source> <volume>13</volume> (<issue>8</issue>), <fpage>11150</fpage>&#x2013;<lpage>11169</lpage>. <pub-id pub-id-type="doi">10.18632/aging.202776</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raigani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Santiago</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ohman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heaney</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baptista</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>T. M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Pan-caspase inhibition during normothermic machine perfusion of discarded livers mitigates <italic>ex situ</italic> innate immune responses</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>940094</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.940094</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="book">
<collab>R Core Team</collab> (<year>2022</year>). <source>R: a language and environment for statistical computing</source>. <publisher-loc>Vienna, Austria</publisher-loc>. <publisher-name>R Foundation for Statistical Computing</publisher-name>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rundshagen</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Postoperative cognitive dysfunction</article-title>. <source>Dtsch. &#xc4;rzteblatt Int.</source> <volume>111</volume> (<issue>8</issue>), <fpage>119</fpage>&#x2013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.3238/arztebl.2014.0119</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Safran</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dalah</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>T. I.</given-names>
</name>
<name>
<surname>Shmoish</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>GeneCards version 3: the human gene integrator</article-title>. <source>Database</source>, <volume>2010</volume>. <pub-id pub-id-type="doi">10.1093/database/baq020</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saliminejad</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Khorram Khorshid</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Soleymani</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Ghaffari</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An overview of microRNAs: biology, functions, therapeutics, and analysis methods</article-title>. <source>J. Cell. Physiology</source> <volume>234</volume> (<issue>5</issue>), <fpage>5451</fpage>&#x2013;<lpage>5465</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27486</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markiel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozier</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res.</source> <volume>13</volume> (<issue>11</issue>), <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sticht</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De La Torre</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Parveen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gretz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>miRWalk: an online resource for prediction of microRNA binding sites</article-title>. <source>PLOS ONE</source> <volume>13</volume> (<issue>10</issue>), <fpage>e0206239</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0206239</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Bioinformatics analysis of genes related to ferroptosis in hepatic ischemia-reperfusion injury</article-title>. <source>Front. Genet.</source> <volume>13</volume>, <fpage>1072544</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2022.1072544</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kirsch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Koutrouli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nastou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mehryary</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hachilif</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>The STRING database in 2023: Protein&#x2013;protein association networks and functional enrichment analyses for any sequenced genome of interest</article-title>. <source>Nucleic acids Res.</source> <volume>51</volume>, <fpage>D638</fpage>&#x2013;<lpage>D646</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac1000</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in mice</article-title>. <source>BMC Pulm. Med.</source> <volume>18</volume> (<issue>1</issue>), <fpage>189</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/s12890-018-0744-z</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Differentially expressed lncRNAs and miRNAs with associated ceRNA networks in aged mice with postoperative cognitive dysfunction</article-title>. <source>Oncotarget</source> <volume>8</volume> (<issue>34</issue>), <fpage>55901</fpage>&#x2013;<lpage>55914</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.18362</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Rosuvastatin alleviates ischemia/reperfusion injury in cardiomyocytes by downregulating Hsa-miR-24-3p to target upregulated uncoupling protein 2</article-title>. <source>Cell. Reprogr.</source> <volume>21</volume> (<issue>2</issue>), <fpage>99</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1089/cell.2018.0039</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wickham</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <source>ggplot2: elegant graphics for data analysis</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>.</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>clusterProfiler 4.0: a universal enrichment tool for interpreting omics data</article-title>. <source>Innov. Camb. Mass.</source> <volume>2</volume> (<issue>3</issue>), <fpage>100141</fpage>. <pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A mouse model of hepatic ischemia-reperfusion injury demonstrates potentially reversible effects on hippocampal neurons and postoperative cognitive function</article-title>. <source>Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.</source> <volume>25</volume>, <fpage>1526</fpage>&#x2013;<lpage>1536</lpage>. <pub-id pub-id-type="doi">10.12659/MSM.912658</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation <italic>via</italic> evoking microglia activation</article-title>. <source>Behav. Brain Res.</source> <volume>332</volume>, <fpage>145</fpage>&#x2013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2017.05.066</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yazit</surname>
<given-names>N. A. A.</given-names>
</name>
<name>
<surname>Juliana</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>N. I. M. F.</given-names>
</name>
<name>
<surname>Fahmy</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Azmani</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Association of micro RNA and postoperative cognitive dysfunction: a review</article-title>. <source>Mini Rev. Med. Chem.</source> <volume>20</volume> (<issue>17</issue>), <fpage>1781</fpage>&#x2013;<lpage>1790</lpage>. <pub-id pub-id-type="doi">10.2174/1389557520666200621182717</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <source>Visualization of functional enrichment result R package</source>.</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lyu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Dexmedetomidine ameliorates hippocampus injury and cognitive dysfunction induced by hepatic ischemia/reperfusion by activating SIRT3-mediated mitophagy and inhibiting activation of the NLRP3 inflammasome in young rats</article-title>. <source>Oxidative Med. Cell. Longev.</source> <volume>2020</volume>, <fpage>7385458</fpage>. <pub-id pub-id-type="doi">10.1155/2020/7385458</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>CCL2&#x2013;CCR2 signaling promotes hepatic ischemia/reperfusion injury</article-title>. <source>J. Surg. Res.</source> <volume>202</volume> (<issue>2</issue>), <fpage>352</fpage>&#x2013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2016.02.029</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lyu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Exosomes mediate hippocampal and cortical neuronal injury induced by hepatic ischemia-reperfusion injury through activating pyroptosis in rats</article-title>. <source>Oxidative Med. Cell. Longev.</source> <volume>2019</volume>, <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1155/2019/3753485</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>hsa-miR-34a-5p ameliorates hepatic ischemia/reperfusion injury Via targeting HNF4&#x3b1;</article-title>. <source>Turkish J. Gastroenterology</source> <volume>33</volume> (<issue>7</issue>), <fpage>596</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.5152/tjg.2022.21169</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Gene microarray analysis of expression profiles in liver ischemia and reperfusion</article-title>. <source>Mol. Med. Rep.</source> <volume>16</volume> (<issue>3</issue>), <fpage>3299</fpage>&#x2013;<lpage>3307</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2017.6966</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>